Complete financial analysis of Al Hammadi Company For Development and Investment (4007.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Al Hammadi Company For Development and Investment, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Insurance Australia Group Limited (IAUGF) Income Statement Analysis – Financial Results
- RWE Aktiengesellschaft (RWEOY) Income Statement Analysis – Financial Results
- EOG Resources, Inc. (EOG) Income Statement Analysis – Financial Results
- Ramsdens Holdings PLC (RSDEF) Income Statement Analysis – Financial Results
- LifeTech Scientific Corporation (LFTSF) Income Statement Analysis – Financial Results
Al Hammadi Company For Development and Investment (4007.SR)
About Al Hammadi Company For Development and Investment
Al Hammadi Company For Development and Investment establishes, maintains, manages, and operates hospitals and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services and Pharmaceuticals Products segments. It is also involved in the wholesale and retail trading of medical equipment, pharmaceutical and cosmetic products, and food and beverages; and the acquisition and rental of land for constructing buildings. In addition, the company invests in various industrial projects; and establishes, operates, and maintains commercial centers. It operates three hospitals under the Al Hammadi Hospital name in Olaya, Suwaidi, and Al Nuzha districts of Riyadh. The company was founded in 1985 and is based in Riyadh, the Kingdom of Saudi Arabia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.12B | 951.89M | 991.81M | 974.06M | 893.60M | 708.62M | 481.96M | 561.33M | 481.96M | 434.08M | 378.68M |
| Cost of Revenue | 743.62M | 706.38M | 587.84M | 639.97M | 691.44M | 648.99M | 449.67M | 272.85M | 314.95M | 272.85M | 250.47M | 217.34M |
| Gross Profit | 433.14M | 416.02M | 364.05M | 351.84M | 282.62M | 244.61M | 258.95M | 209.11M | 246.38M | 209.11M | 183.61M | 161.35M |
| Gross Profit Ratio | 36.81% | 37.07% | 38.24% | 35.47% | 29.01% | 27.37% | 36.54% | 43.39% | 43.89% | 43.39% | 42.30% | 42.61% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.71M | 19.76M | 13.85M | 21.44M | 13.96M | 14.17M | 13.64M | 10.37M | 14.01M | 9.23M | 7.40M | 8.72M |
| Selling & Marketing | 9.26M | 2.20M | 2.91M | 3.86M | 10.21M | 9.76M | 0.00 | 120.79M | 1.08M | 687.68K | 200.99K | 785.93K |
| SG&A | 26.14M | 21.96M | 16.76M | 25.30M | 24.17M | 14.17M | 13.64M | 131.16M | 86.86M | 73.44M | 68.10M | 65.61M |
| Other Expenses | 63.89M | 113.84M | 209.61M | 149.83M | 121.26M | 4.28M | 894.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 90.03M | 135.80M | 226.36M | 175.13M | 145.42M | 110.75M | 124.07M | 131.16M | 86.86M | 73.21M | 67.59M | 62.92M |
| Cost & Expenses | 834.19M | 842.18M | 814.20M | 815.10M | 836.86M | 759.73M | 573.75M | 272.85M | 314.95M | 272.85M | 318.05M | 280.26M |
| Interest Income | 0.00 | 18.15M | 13.72M | 23.17M | 34.55M | 0.00 | 0.00 | 0.00 | 3.16M | 3.31M | 319.89K | 1.66M |
| Interest Expense | 25.80M | 21.71M | 15.72M | 25.16M | 34.55M | 31.06M | 19.57M | 13.64M | 6.20M | 107.76K | 0.00 | 0.00 |
| Depreciation & Amortization | 100.10M | 100.41M | 99.57M | 91.45M | 102.41M | 88.43M | 53.04M | 50.41M | -89.86M | -74.86M | 13.61M | 13.60M |
| EBITDA | 446.86M | 388.64M | 228.80M | 198.83M | 246.42M | 224.22M | 187.50M | 153.41M | 156.52M | 134.25M | 125.71M | 112.03M |
| EBITDA Ratio | 37.97% | 35.31% | 25.49% | 28.71% | 25.30% | 25.09% | 26.65% | 20.61% | 27.88% | 27.86% | 28.96% | 28.04% |
| Operating Income | 342.57M | 291.78M | 131.23M | 175.88M | 146.54M | 138.14M | 142.58M | 209.11M | 246.38M | 209.11M | 112.10M | 92.58M |
| Operating Income Ratio | 29.11% | 26.00% | 13.79% | 17.73% | 15.04% | 15.46% | 20.12% | 43.39% | 43.89% | 43.39% | 25.82% | 24.45% |
| Total Other Income/Expenses | -21.62M | -17.63M | -13.67M | -25.05M | -37.08M | -33.42M | -19.57M | -19.05M | -3.04M | 3.20M | 3.61M | 4.19M |
| Income Before Tax | 320.96M | 274.15M | 117.56M | 150.71M | 109.46M | 104.72M | 123.02M | 85.68M | 150.33M | 134.15M | 115.70M | 96.77M |
| Income Before Tax Ratio | 27.27% | 24.43% | 12.35% | 15.20% | 11.24% | 11.72% | 17.36% | 17.78% | 26.78% | 27.83% | 26.65% | 25.55% |
| Income Tax Expense | 17.62M | 16.81M | 18.69M | 19.88M | 16.46M | 14.91M | 15.05M | 11.00M | 9.00M | 5.20M | 4.20M | 2.50M |
| Net Income | 303.33M | 257.34M | 90.09M | 130.83M | 93.00M | 89.81M | 107.96M | 74.68M | 141.33M | 128.95M | 111.50M | 94.27M |
| Net Income Ratio | 25.78% | 22.93% | 9.46% | 13.19% | 9.55% | 10.05% | 15.24% | 15.49% | 25.18% | 26.75% | 25.69% | 24.89% |
| EPS | 1.90 | 1.61 | 0.56 | 0.82 | 0.58 | 0.56 | 0.68 | 0.47 | 0.89 | 0.80 | 1.00 | 0.85 |
| EPS Diluted | 1.90 | 1.61 | 0.56 | 0.82 | 0.58 | 0.56 | 0.68 | 0.47 | 0.89 | 0.80 | 1.00 | 0.85 |
| Weighted Avg Shares Out | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 112.00M | 110.42M |
| Weighted Avg Shares Out (Dil) | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 160.00M | 112.00M | 110.42M |
Source: https://incomestatements.info
Category: Stock Reports